Testing effectiveness (Phase 2)Looking for participantsNCT06715982
What this trial is testing
JAK Inhibitors for Solid Malignant Tumor Patients With Immune Checkpoint Inhibitors-related Dermatitis: A Open-lable, Single Arm, Phase IIa Trial
Who this might be right for
Immune Checkpoint Inhibitors (ICI)-Related Dermatitis
Shixiu Wu 35